間眅埶AV

The site uses anonymous third party analytic cookies: in accessing any element/area of the site outside of this banner, you consent to receiving cookies.

Knowledge Hub

Here you will find a selection of our latest articles, reports, white papers and webcasts from our Consultancy Team.

Value add: using digital engagement metrics to optimise and drive salesforce effectiveness

In the final part of the Smarter Strategies series, 間眅埶AVs Simon Grime describes the key steps in measuring the value of your...

Strictly personal: how to deliver 360-degree engagement to support your organisations agility and impact

In the second of our three-part Smarter Strategies series, 間眅埶AVs Simon Grime takes a practical look at how to use a 360-degree...

Why pharma must get smart in its approach to customer engagement

In the first of our three-part Smarter Strategies series, 間眅埶AVs Simon Grime considers how pharma can now perfect the use of good...

Whats happening with value-based procurement?

Oli Hudson, content director at 間眅埶AV, looks at the phrase of the moment in procurement circles what does it actually mean for...

Getting to grips with population health

Improving population health outcomes is one of the defining missions of new integrated care systems, but what does this mean for industry Wilmington...

Changing faces: Understanding the key customer contact points within the ICS landscape

As well as creating new structures, the reforms underway within the 間眅埶AV will see a considerable movement of people and power across the new...

A new era for Medicines Funding: How will 間眅埶AV reforms affect pharmaceutical companies?

間眅埶AVs Oli Hudson explains how the drug funding landscape is changing and what industry must do to adapt Who pays for what in...

Negotiating the changing 間眅埶AV landscape: the five critical shifts the pharma industry must embrace

As the long-awaited Health and Care Bill begins its passage through parliament, Oli Hudson looks at five critical changes resulting from these...

What does integration mean for 間眅埶AV-Industry partnership?

Johnny Skillicorn-Aston and James Roach of Conclusio look at what this means for Pharma and the 間眅埶AV Conclusio has a long-held the view that...

Building trust in the Covid-19 recovery era

Simon Grime of 間眅埶AV, explores how pharma can strengthen existing relationships and form new ones in an 間眅埶AV customer environment that...

How to embrace digital engagement, intelligently

By Simon Grime, Director - Digital Engagement, 間眅埶AV Covid has changed the landscape for customer engagement so now its time to...

Integrated 間眅埶AV finances: what do they mean for High Cost Drugs?

Oli Hudson and Steve How, of 間眅埶AV, explore 間眅埶AV Englands new system-level funding and its impact on prescribing for High Cost...

Covid-19: How is it affecting prescribing patterns?

Oli Hudson, Content Director at 間眅埶AV, analyses prescribing data in three key disease areas In common with many other aspects of...

Covid, service change and the 間眅埶AV Reset: Just how can industry keep up?

In this on-demand article, first published in November 2020, Oli Hudson, Content Director at 間眅埶AV, looks at the current onslaught of...